================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             ----------------------

                                    FORM 10-Q

(Mark One)
[ X ]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 1997

                                       OR

[   ]    TRANSITION  REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE  ACT OF 1934 for the  transition  period  from  __________  
         to __________


                        Commission file number: 000-22673



                            SCHICK TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)

              Delaware                              11-3374812
  (State or other jurisdiction of
   incorporation or organization)                (I.R.S. Employer
                                               Identification Number)



              31-00 47th Avenue                        11101
          Long Island City, New York                (Zip Code)
   (Address of principal executive offices)

       Registrant's telephone number, including area code: (718) 937-5765



Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes [ ] No [ X ]

As of July 31, 1997, 9,969,731 shares of common stock, par value $.01 per share,
were outstanding.



================================================================================



<PAGE>
<TABLE>
<CAPTION>

                            SCHICK TECHNOLOGIES, INC.

                                TABLE OF CONTENTS

<S>      <C>                                                                                    <C>
PART I.  FINANCIAL INFORMATION:


         Item 1.  Financial Statements:

                  Consolidated Balance Sheet as of March 31, 1997 and June
                  30, 1997 (unaudited) ....................................................     Page 3
                  Consolidated Statement of Operations for the three months
                  ended June 30, 1996 and 1997 (unaudited) ................................     Page 4
                  Consolidated Statement of Cash Flows for the three months
                  ended June 30, 1996 and 1997 (unaudited) ................................     Page 5
                  Notes to Consolidated Financial Statements
                  (unaudited)..............................................................     Page 6

         Item 2.  Management's Discussion and Analysis of Financial Condition
                           and Results of Operations.......................................     Page 8

PART II.  OTHER INFORMATION:

         Item 1.  Legal Proceedings........................................................     Page 10
         Item 2.  Changes in Securities....................................................     Page 10
         Item 6.  Exhibits and Reports on Form 8-K.........................................     Page 10

SIGNATURE..................................................................................     Page 11

INDEX TO EXHIBITS..........................................................................     Page E-1

</TABLE>

<PAGE>

<TABLE>
<CAPTION>

PART I.  FINANCIAL INFORMATION
Item 1.  Financial Statements

                                        Schick Technologies, Inc.
                                        Consolidated Balance Sheet

                        Assets                                    March 31, 1997              June 30, 1997
                                                                  --------------              -------------
<S>                                                                  <C>                        <C>        
Current assets                                                                                 (unaudited)
     Cash and cash equivalents                                       $ 1,710,429                $   656,090
     Short-term investments                                            2,313,226                  1,757,756
     Accounts receivable, net of allowance for
       doubtful accounts of $50,000 at March 31,
       1997 and $70,000 at June 30, 1997                               1,927,993                  2,563,410
     Inventories                                                       2,510,959                  4,694,263
     Deferred offering costs                                                 ---                    977,115
     Prepayments and other current assets                                327,220                    279,821
                                                                     -----------                -----------
         Total current assets                                          8,789,827                 10,928,455

Equipment, net                                                         1,644,528                  2,182,493
Investments                                                              490,000                    490,000
Other assets                                                             135,727                    164,488
                                                                     -----------                -----------

         Total assets                                                $11,060,082                $13,765,436
                                                                     ===========                ===========

       Liabilities and Stockholders' Equity

Current liabilities
  Accounts payable and accrued expenses                              $ 2,102,293                $ 5,020,185
  Accrued salaries and commissions                                       540,061                    808,419
  Provision for warranty obligations                                     329,426                    455,292
  Deferred revenue                                                       141,017                    199,148
  Deposits from customers                                                136,628                    130,090
  Capital lease obligations, current                                      22,200                     23,155
                                                                     -----------                -----------
         Total current liabilities                                     3,271,625                  6,636,289

Notes payable                                                          1,512,833                  1,512,833
Accrued interest on notes payable                                        101,654                    140,851
Capital lease obligations, long-term                                      86,991                     80,809
                                                                     -----------                -----------
         Total liabilities                                             4,973,103                  8,370,782
                                                                     -----------                -----------

Commitments                                                                  ---                        ---

Stockholders' equity

    Preferred stock ($.01 par value; 2,500,000
      shares authorized; none issued and outstanding)                        ---                        ---
    Common stock ($.01 par value; 25,000,000 shares
      authorized; 7,957,231 shares issued and
      outstanding at March 31, 1997 and June 30,                          79,572                     79,572
      1997)
    Additional paid-in capital                                         7,562,766                  7,567,813
    Accumulated deficit                                               (1,555,359)                (2,252,731)
                                                                     -----------                -----------
         Total stockholders' equity                                    6,086,979                  5,394,654

           Total liabilities and stockholders' equity                $11,060,082                $13,765,436
                                                                     ===========                ===========

 The accompanying notes are an integral part of these consolidated financial statements.

</TABLE>

<PAGE>

<TABLE>
<CAPTION>

                                        Schick Technologies, Inc.
                                   Consolidated Statement of Operations
                                               (unaudited)


                                                           Three months ended June 30,
                                                           ---------------------------
                                                        1996                      1997
                                                        ----                      ----

<S>                                                <C>                       <C>         
Revenue, net                                       $  2,626,882              $  6,040,031
Cost of sales                                         1,440,647                 2,830,563
                                                   ------------              ------------
         Gross profit                                 1,186,235                 3,209,468
                                                   ------------              ------------

Operating expenses
   Selling and marketing                                871,990                 1,795,583
   General and administrative                           386,202                   877,664
   Research and development                             224,381                   638,454
   Patent litigation settlement                             ---                   600,000
                                                   ------------              ------------
         Total operating expenses                     1,482,573                 3,911,701
                                                   ------------              ------------ 
Loss from operations                                   (296,338)                 (702,233)
                                                   ------------              ------------ 

Other income (expense)
   Interest income                                        4,705                    48,437
   Interest expense                                     (25,269)                  (43,576)
                                                   ------------              ------------ 
         Total other income (expense)                   (20,564)                    4,861
                                                   ------------              ------------ 

         Net loss                                  $   (316,902)             $   (697,372)
                                                   ============              ============ 

         Net loss per common share                 $      (0.04)             $      (0.08)
                                                   ============              ============ 

         Weighted average shares outstanding          8,054,419                 8,400,822
                                                   ============              ============ 













 The accompanying notes are an integral part of these consolidated financial statements.

</TABLE>

<PAGE>

<TABLE>
<CAPTION>

                                        Schick Technologies, Inc.
                                   Consolidated Statement of Cash Flows
                                               (unaudited)

                                                                             Three months ended June 30,
                                                                             ---------------------------
                                                                             1996                   1997
                                                                             ----                   ----

<S>                                                                     <C>                   <C>    
Net cash flows from operating activities
Net loss                                                                 $ (316,902)           $  (697,372)
Adjustments to reconcile net loss to net cash used in
   operating activities
   Depreciation                                                              50,568                125,248
   Amortization                                                              27,500                    ---
   Stock and option grant compensation                                          ---                  5,047
   Accrued interest on investments                                              ---                 14,482
Changes in assets and liabilities
  Accounts receivable                                                        90,135               (635,417)
  Inventories                                                              (209,566)            (2,183,304)
  Prepayments and other current assets                                      (23,729)                47,399
  Other assets                                                              (47,607)               (28,761)
  Accounts payable and accrued expenses                                     501,225              3,312,116
  Deferred revenue                                                           36,676                 58,131
  Deposits from customers                                                     1,631                 (6,538)
  Accrued interest on notes payable                                             ---                 39,197
                                                                         ----------            -----------   
         Net cash provided by operating activities                          109,931                 50,228
                                                                         ----------            -----------

Cash flows from investing activities
  Purchases of held-to-maturity investments                                     ---               (101,272)
  Proceeds from maturities of held-to-maturity investments                      ---                642,260
  Capital expenditures                                                     (127,402)              (663,213)
                                                                         ----------            -----------
   Net cash used in investing activities                                   (127,402)              (122,225)
                                                                         ----------            -----------

Cash flows from financing activities
  Deposits on common stock and warrant subscriptions                      1,465,000                    ---
  Deferred offering costs                                                       ---               (977,115)
  Principal payments on capital lease obligations                            (5,479)                (5,227)
                                                                         ----------            -----------
        Net cash provided by financing activities                         1,459,521               (982,342)
                                                                         ----------            -----------

Net increase (decrease) in cash and cash equivalents                      1,442,050             (1,054,339)
Cash and cash equivalents at beginning of period                            524,917              1,710,429
                                                                         ----------            -----------

Cash and cash equivalents at end of period                               $1,966,967            $   656,090
                                                                         ==========            ===========











 The accompanying notes are an integral part of these consolidated financial statements.

</TABLE>

<PAGE>


                            Schick Technologies, Inc.
             Notes to Consolidated Financial Statements (unaudited)

1.    Basis of Presentation

     The consolidated financial statements of Schick Technologies,  Inc. and its
     subsidiary  (collectively  the "Company")  have been prepared in accordance
     with  generally  accepted  accounting   principles  for  interim  financial
     information  and the rules of the Securities and Exchange  Commission  (the
     "SEC") for  quarterly  reports on Form 10-Q and do not  include  all of the
     information  and  footnote   disclosures  required  by  generally  accepted
     accounting principles for complete financial  statements.  These statements
     should be read in  conjunction  with the audited  financial  statements and
     notes thereto for the year ended March 31, 1997,  included in the Company's
     Prospectus dated July 1, 1997 forming a part of the Company's  Registration
     Statement on Form S-1, as amended ("Form S-1"),  which was initially  filed
     with the SEC on May 13, 1997.

     In the  opinion of  management,  the  accompanying  unaudited  consolidated
     financial  statements  include  all  adjustments   (consisting  of  normal,
     recurring  adjustments)  necessary  for a fair  presentation  of results of
     operations for the interim periods. The results of operations for the three
     months ended June 30, 1997 are not necessarily  indicative of the result of
     operations to be expected for the full year ending March 31, 1998.

2.    Restructuring and recapitalization

     In connection with the Company's  initial public offering (the "IPO") under
     the  Securities  Act of  1933,  as  amended,  the  Company  engaged  in the
     following restructuring and recapitalization  transactions.  In April 1997,
     Schick  Technologies,  Inc.  ("Schick  Delaware" or "the  Company") and its
     wholly owned subsidiary,  STI Acquisition  Corporation  ("STI") were formed
     under the General  Corporation Law of the State of Delaware for the purpose
     of forming a holding  company and  changing the state of  incorporation  of
     Schick Technologies, Inc., a New York corporation ("Schick New York" or the
     "Predecessor  Corporation").  Effective  June 4, 1997 (pursuant to a merger
     agreement  among Schick  Delaware,  the  Predecessor  Corporation and STI),
     Schick  Delaware  issued  7,957,231  shares of its common stock for all the
     outstanding  common  stock  of the  Predecessor  Corporation.  STI  and the
     Predecessor  Corporation  merged and the  Predecessor  Corporation  was the
     survivor  of the merger,  and became a  wholly-owned  subsidiary  of Schick
     Delaware.  In connection with the restructuring and merger,  the holders of
     the Predecessor  Corporation's  outstanding  warrants and options converted
     such  warrants  and  options  to  similar  warrants  and  options of Schick
     Delaware  (based on the same  ratio of  exchange,  2.8  shares for 1 share,
     applicable to the common stock  exchange).  Schick  Delaware's  articles of
     incorporation also authorize  2,500,000 shares of preferred stock, $.01 par
     value.

     The 1996 Stock Option Plan of the  Predecessor  Corporation  was amended by
     Schick Delaware and the shares available for issuance  pursuant to the Plan
     were adjusted to 470,000.  Schick Delaware also  implemented its 1997 Stock
     Option Plan for  Non-Employee  Directors  ("the  Directors  Plan")  whereby
     nonqualified  options  to  purchase  up to 35,000  shares of the  Company's
     common stock may be granted to non-employee directors.  Each option granted
     under the Directors Plan becomes exercisable on the second anniversary date
     of its grant and must have an exercise price equal to the fair market value
     of the Company's common stock on the date of grant.

     All common  shares,  stock  options,  warrants  and  related per share data
     reflected in the accompanying  financial  statements and notes thereto have
     been  presented  as if the  recapitalization  had  been  effective  for all
     periods presented.

     References herein to the operations and historical financial information of
     the  "Company"  prior  to  the  date  of  the  restructuring  refer  to the
     operations  and  historical   financial   information  of  the  Predecessor
     Corporation.

     The  consolidated  financial  statements of the Company,  subsequent to the
     restructuring, include the accounts of Schick Delaware and its wholly owned
     subsidiary,  Schick New York. All  significant  intercompany  balances have
     been eliminated.

<PAGE>


3.    New Accounting Pronouncements

     In February 1997, the Financial Accounting Standards Board issued statement
     of Financial Accounting Standards No. 128, "Earnings per Share" ("FAS 128")
     which requires  presentation  of basic earnings per share ("Basic EPS") and
     diluted  earnings  per  share  ("Diluted  EPS") by all  entities  that have
     publicly traded common stock or potential common stock (options,  warrants,
     convertible  securities or  contingent  stock  arrangements).  FAS 128 also
     requires  presentation  of earnings  per share by an entity that has made a
     filing  or is in  the  process  of  filing  with  a  regulatory  agency  in
     preparation for the sale of those securities in a public market.  Basic EPS
     is computed by dividing  income  available  to common  stockholders  by the
     weighted-average  number of common  shares  outstanding  during the period.
     Diluted  EPS  gives  effect  to  all  dilutive   potential   common  shares
     outstanding  during the  period.  The  computation  of Diluted EPS does not
     assume conversion, exercise or contingent exercise of securities that would
     have an  antidilutive  effect on earnings.  The  statement is effective for
     both interim and annual  periods ending after December 15, 1997. The effect
     on the Company's  earnings per share resulting from the adoption of FAS 128
     is not expected to be significant.

     In June 1997, the Financial  Accounting Standards Board issued statement of
     Financial Accounting Standards  No. 130, "Reporting  Comprehensive  Income"
     ("FAS 130"),   which   requires  the  presentation  of  the  components  of
     comprehensive income in a  company's   financial  statement  for  reporting
     periods  beginning subsequent to December  15, 1997.  Comprehensive  income
     is  defined  as  the  change  in  a  company's  equity  during  a financial
     reporting  period from transactions  and other  circumstances from nonowner
     sources  (including cumulative  translation  adjustments,  minimum  pension
     liabilities  and unrealized gains/losses on available for sale securities).
     The adoption of FAS  130  is not expected  to have a material impact on the
     Company's financial statements.

4.    Inventories

     Inventories  at March  31,  1997 and June  30,  1997 are  comprised  of the
following:

                                           March 31             June 30
                                           --------             -------

       Raw materials                     $1,671,010           $3,161,491
       Work-in-process                      421,863              439,924
       Finished goods                       418,086            1,092,848
                                         ----------           ----------
                Total inventories        $2,510,959           $4,694,263
                                         ==========           ==========



5.    Subsequent Events

     In July 1997, the Company  completed the IPO,  selling  2,012,500 shares of
     common stock at a price of $18.50 per share providing gross proceeds to the
     Company of $37,231,250 and net proceeds,  after underwriting  discounts and
     commissions  and estimated  offering  expenses  payable by the Company,  of
     approximately $33,731,250.

     In July 1997,  upon the  declaration of the  effectiveness  of the Form S-1
     filed in connection  with the IPO, the Company  repaid,  as required by the
     note  agreement,  a  secured  note  payable  in  the  principal  amount  of
     $1,512,833 and accrued interest thereon in the amount of $144,296.

     In July 1997,  the Company,  in connection  with the  settlement of certain
     pending patent  litigation  involving a United States patent  directed to a
     display  for  digital   dental   radiographs,   was  granted  a  worldwide,
     non-exclusive  fully paid license covering such patent in consideration for
     a payment by the Company of  $600,000.  The Company has recorded an accrued
     liability and expensed the license fee in the quarter ended June 30, 1997.

     In July  1997,  the  Company  entered  into a letter of intent to  purchase
     certain assets of Keystone  X-Ray,  Inc., a manufacturer of x-ray equipment
     for the medical and dental radiology  field, for $1.5 million.  The Company
     expects to complete this transaction within 90 days.


<PAGE>


                           Management's Discussion and
                         Analysis of Financial Condition
                            and Results of Operations

This Quarterly Report on Form 10-Q contains  forward-looking  statements  within
the  meaning of Section  27A of the  Securities  Act of 1933,  as  amended,  and
Section 21E of the Securities Exchange Act of 1934, as amended.  Actual results,
events and  circumstances  could differ  materially from those set forth in such
statements due to various  factors.  Such factors include the changing  economic
and competitive conditions in the dental digital radiography market,  regulatory
approvals,   including   approvals   related  to   accuDEXA(TM),   technological
developments and other risks and uncertainties,  including those detailed in the
Company's other filings with the Securities and Exchange Commission.

References herein to the Company include Schick New York.

General
-------

The Company  designs,  develops and  manufactures  digital  imaging  systems and
devices  for the dental and  medical  markets.  In the field of  dentistry,  the
Company has developed,  and currently  manufactures  and markets,  an intra-oral
digital  radiography  system.  The  Company has also  developed  a bone  mineral
density assessment  device to assist in the diagnosis of osteoporosis,  which is
scheduled to be  introduced  in the second half of 1997,  pending FDA  marketing
clearance.  In  addition,  the  Company is  developing  large-area  radiographic
imaging devices for digital mammography.

Results of Operations
---------------------

Net revenue for the three months ended June 30, 1997 increased $3,413,149 (130%)
to $6,040,031  from  $2,626,882 for the comparable  period of 1996. The increase
was  attributable  principally  to an increase  in the number of CDRTM  products
sold, including sales of the Company's CDRCamTM which was introduced in February
1997.  The number of products  sold was  positively  affected  by the  Company's
increased  expenditures  on sales and  marketing,  personnel  recruiting,  sales
events and other promotional activities.

Cost of sales for the three  months  ended June 30,  1997  increased  $1,389,915
(96%) to  $2,830,563  (46.9%  of net  revenue)  from  $1,440,647  (54.8%  of net
revenue) for the comparable period of 1996. The increase was due to the increase
in sales of the Company's  CDRTM  products.  The decrease as a percentage of net
revenue was primarily  due to increased  manufacturing  efficiencies,  increased
production  yields and economies of scale generated by an increase in the number
of CDRTM products sold.

Selling  and  marketing  expenses  for the three  months  ending  June 30,  1997
increased  $923,593  (106%) to  $1,795,583  (29.7% of net revenue) from $871,990
(33.1% of net  revenue)  for the  comparable  period of 1996.  The  increase  in
dollars  was  attributable  principally  to  the  hiring  and  training  of  new
salespeople as the Company  continued to increase the size of its national sales
force.  In  addition,  the  Company  significantly   increased  its  promotional
activities to create greater market  awareness and developed  market  strategies
for new products.

General and  administrative  expenses  for the three  months ended June 30, 1997
increased  $491,462  (127%) to $877,664  (14.5% of net  revenue)  from  $386,202
(14.7% of net  revenue)  for the  comparable  period of 1996.  The  increase was
primarily attributable to the hiring of administrative  personnel and legal fees
associated with patent infringement litigation.

Research  and  development  expenses  for the three  months  ended June 30, 1997
increased $414,073 (184%) to $638,454 (10.6% of net revenue) from $224,381 (8.5%
of net revenue) for the comparable period of 1996. The increase was attributable
to the  expenses  associated  with the  development  of a bone  mineral  density
assessment   device,   enhancements  to  the  Company's   products  and  initial
development of a mammography system.

In July 1997, the Company,  in connection with the settlement of certain pending
patent  litigation  involving a United States  patent  directed to a display for
digital dental  radiographs,  was granted a worldwide,  non-exclusive fully paid
license  covering such patent in  consideration  for a payment by the Company of



<PAGE>

$600,000. The Company has recorded an accrued liability and expensed the license
fee in the quarter ended June 30, 1997.

Interest  income  increased  to $48,437 in the three  months ended June 30, 1997
from $4,705 in the  comparable  period of 1996 due to higher cash  balances  and
investments  in  interest-bearing  securities  which  were  purchased  with  the
proceeds of the May 1996 equity private placement. Interest expense increased to
$43,576  for the  three-month  period  ended June 30,  1997 from  $25,269 in the
comparable period of 1996. Interest expense was attributable  principally to the
Merck Loan (as defined below).

As a result  of  increases  in  selling  and  marketing  expenses,  general  and
administrative  expenses,  research and development expenses, and the settlement
of the litigation described above, the Company sustained a net loss of $697,372,
or $0.08 per share for the three  months  ended  June 30,  1997 as  compared  to
a loss of $316,902, or $0.04 per share, in the comparable quarter in 1996.

Liquidity and Capital Resources
-------------------------------

As of June 30, 1997 the Company had an accumulated deficit of $2,252,731 and has
not yet generated positive cash flow from operations in any fiscal year. At June
30, 1997, the Company had $656,090 in cash and cash  equivalents,  $1,757,756 in
short-term  investments and $3,315,051 in working capital compared to $1,710,429
in  cash  and  cash  equivalents,   $2,313,226  in  short  term-investments  and
$5,518,302 in working capital at March 31, 1997. The decrease in working capital
for the three months ended June 30, 1997 is  primarily  attributable  to capital
expenditures,  in the amount of approximately $663,000, and $977,000 of deferred
offering costs incurred in connection with the Company's IPO.

On July 7, 1997 the Company sold 1,750,000 shares of common stock in an IPO at a
price  of  $18.50  per  share,  resulting  in net  proceeds  to the  Company  of
approximately  $29,215,170 after deducting estimated expenses.  In addition,  on
July 10, 1997, the Company received approximately  $4,516,080,  net of expenses,
upon the exercise of the underwriters' over-allotment option to purchase 262,500
shares  of common  stock.  A portion  of the  proceeds  from the IPO was used to
retire  the debt due  Merck & Co. in the  principal  amount  of  $1,512,833  and
interest of $144,296 (the "Merck Loan"). The remaining proceeds will be used (i)
to expand the Company's  research and development  capabilities,  (ii) to expand
its sales  and  marketing  effort  and (iii) for  working  capital  and  general
corporate  purposes.  Pending such uses,  the Company  intends to invest the net
proceeds in investment-grade,  interest-bearing  securities.  From time to time,
the Company may evaluate potential acquisitions of businesses and product lines,
which would complement or enhance the business of the Company.  Depending on the
cash  requirements  of any  such  acquisition,  the  Company  may  finance  such
acquisition, in whole or in part, with a portion of the net proceeds of the IPO.

In July 1997,  the Company  entered into a letter of intent to purchase  certain
assets of Keystone  X-Ray,  Inc.,  a  manufacturer  of x-ray  equipment  for the
medical and dental radiology field, for $1.5 million.
The Company expects to complete such transaction within 90 days.

The Company had no material  cash  requirement  for income  taxes in the quarter
ending June 30,  1997.  At June 30,  1997,  the  Company's  net  operating  loss
carryforward was approximately $955,000,  portions of which begin to expire in
2008.




<PAGE>


  PART II         OTHER INFORMATION

Item 1.  Legal Proceedings.
         ------------------

                  The Company had been sued by Radworks Corp.  ("Radworks")  and
the Board of Regents of the  University of Texas.  That suit,  filed in December
1996 in the United  States  District  Court for the  Western  District of Texas,
alleged that the Company's  CDR(TM)  system  infringed  United States Patent No.
5,179,579 (the "'579  patent").  The `579 patent is directed to a display system
for  digital  dental  radiographs.  Radworks  and the  Board of  Regents  of the
University of Texas were seeking a permanent injunction and unspecified damages,
including enhanced damages for the Company's purported willful  infringement and
an award of attorney fees.

         The Company reached a settlement of the litigation  between the Company
and Radworks and the Board of Regents of the  University  of Texas in July 1997.
Terms of the settlement consist of an aggregate $600,000 payment to Radworks and
the Board of Regents of the  University  of Texas in exchange  for a fully paid,
worldwide, non-exclusive license under the `579 Patent.

Item 2.  Changes in Securities
         ---------------------

         During  the three  months  ended  June 30,  1997,  pursuant  to certain
provisions  contained  in the  Company's  By-Laws  which  are  described  in the
Company's Form 8-A dated June 10, 1997, restrictions were imposed on the sale or
other disposition of certain shares of common stock, which  restrictions  expire
on December 27, 1997.

Item 6.  Exhibits and Reports on Form 8-K
         --------------------------------

         (a)      Exhibits:

                  The exhibits  listed in the following table have been filed as
         part of this Quarterly Report on Form 10-Q:

         Exhibit Number

         (11) Statement re: Computation of Per Share Earnings.

         (27) Financial Data Schedule.

         (b)      Reports on Form 8-K:

                  No Report on Form 8-K was filed  during the  Quarter for which
         this Quarterly Report on Form 10-Q is filed.


<PAGE>



                            SCHICK TECHNOLOGIES, INC.


                                    SIGNATURE


Pursuant  to the  requirement  of the  Securities  Exchange  Act  of  1934,  the
registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                              SCHICK TECHNOLOGIES, INC.


Date:   August 13, 1997                By: /s/ David B. Schick
                                          ---------------------------------- 
                                                David B. Schick
                                                President and 
                                                Chief Executive Officer
                                                



                                       By: /s/ David B. Spector
                                          ---------------------------------- 
                                                David B. Spector
                                                Chief Financial Officer and
                                                Treasurer
                                                (Principal Financial Officer)



<PAGE>





                            SCHICK TECHNOLOGIES, INC.

                                INDEX TO EXHIBITS

                                                                   Sequentially
Exhibit No.   Description                                          Numbered Page
-----------   -----------                                          -------------

   11         Statement re: computation of per share earnings
   27         Financial Data Schedule










































                                                   E-1